Financial Synergies Wealth Advisors, Inc. Abbott Laboratories Transaction History

Financial Synergies Wealth Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	BUY	$109.52 - $120.96 $17,304 - $19,111	158 Added 72.81%	375 $42.6 Million
Q4 2023 Apr 04, 2024	SELL	$90.19 - $110.4 $14,159 - $17,332	-157 Reduced 41.98%	217 $23.8 Million
Q2 2023 Apr 04, 2024	SELL	$100.78 - $112.29 $3,124 - $3,480	-31 Reduced 7.65%	374 $40.7 Million
Q1 2023 Apr 04, 2024	BUY	$96.86 - $114.01 $18,209 - $21,433	188 Added 86.64%	405 $41 Million
Q4 2022 Apr 04, 2024	BUY	$95.06 - $111.52 $18,346 - $21,523	193 Added 804.17%	217 $23.8 Million

Q2 2022 Apr 04, 2024	BUY	$102.07 - $123.37 $2,449 - $2,960	24 New	24 $2.61 Million

3,109

1.29B

8.43M

8.19M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $184B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Financial Synergies Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Synergies Wealth Advisors, Inc. with notifications on news.